The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: A flow cytometric study

British Journal of Cancer

Volumn 74, Issue 12, 1996, Pages 1935-1943

  Ormerod, M G ^a,b   Orr, R M ^a   O'Neill, C F ^a   Chwalinski, T ^a   Titley, J C ^a   Kelland, L R ^a   Harrap, K R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Apoptosis; Cell cycle; Flow cytometry; Pt(IV) dicarboxylates

Indexed keywords

AMMINEBISBUTYRATODICHLORO(CYCLOHEXYLAMINE)PLATINUM; DNA; JM 223; JM 244; PLATINUM DERIVATIVE; SATRAPLATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG MECHANISM; FLOW CYTOMETRY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030458559     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.656     Document Type: Article

References (35)

1. BARRY MA, BEHNKE CA AND EASTMAN A. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40, 2353-2362.
2. DARZYNKIEWICZ Z, BRUNO S, DEL BINO G, GORCZYCA W, HOTZ MA, LASSOTA P AND TRAGANOS F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
3. DEMARCQ C, BASTIAN B AND REMVIKOS Y. (1992). Brd Urd/DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry, 13, 416-422.
4. DIVE C AND HICKMAN JA. (1991). Drug target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer. 64, 192-196.
5. EASTMAN A. (1987). The formation, isolation and characterisation of DNA adducts produced by anticancer platinum complexes. Pharmacol. Ther., 34, 155-168.
6. FUJIKANE T, SHIMIZU T, TSUJII T, ISHIDA S, OHSAKI Y AND ONODERA S. (1989). Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells. Cytometry, 10, 788-795.
7. GIANDOMENICO CM, ABRAMS MJ, MURRER BA, VOLLANO JF, HARRAP KR, GODDARD PM, KELLAND LR AND MORGAN SE. (1991). Synthesis and reactions of a new class of orally active Pt(IV) antitumour complexes. In Proceedings of the Sixth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Howell SB. (ed.) pp. 93-100. Plenum Press: New York.
8. GORE M, FRYATT I, WILTSHAW K, DAWSON T, ROBINSON B AND CALVERT AH. (1989). Cisplatin/carboplatin cross-resistance in ovarian cancer. Br. J. Cancer. 60, 767-769.
9. HARRAP KR. (1985). Preclinical studies identifying carboplatin as a viable cisplatin alternative. Cancer Treat. Rev., 12, 21-33.
10. HARRAP KR, KELLAND LR, JONES M, GODDARD PM, ORR RM, MORGAN SE, MURRER BA, ABRAMS MJ AND GIANDOMENICO CM. (1991a). Platinum coordination complexes which circumvent cisplatin resistance. Adr. Enzyme Regul., 31, 31-43.
11. HARRAP KR, MURRER BA, GIANDOMENICO CM, MORGAN SE, KELLAND LR, JONES M, GODDARD PM AND SCHURIG, J. (1991b). Ammine/amine platinum IV dicarboxylates: a novel class of complexes which circumvent intrinsic cisplatin resistance. In Proceeding of the Sixth International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Howell SB. (ed.) pp. 391-399. Plenum Press: New York.
12. HICKMAN JA. (1992). Apoptosis induced by anticancer drugs. Cancer Metast. Rev., 11, 121-139.
13. KELLAND LR, MURRER BA, ABEL G, GIANDOMENICO CM, MISTRY P AND HARRAP KR. (1992a) Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines. Cancer Res., 52, 822-828.
14. KELLAND LR, MISTRY P, ABEL G, LOB SY, O'NEILL CF AND MURRER BA. (1992b). Mechanism-related circumvention of acquired cis-diamminechloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates. Cancer Res., 52, 3857-3864.
15. LOEHRER PJ AND EINHORN LH. (1984). Cisplatin, diagnosis, treatment. Ann. Intern. Med., 100, 704-713.
16. MANGIONI C, BOKIS G, PECORELLI S, BRAGMAN K, EPIS A, FAVALLI G, GAMBINO A, LANDONI F, PRESTI M, TORRI W, VASSENA L, ZANABONI F AND MARSONI S. (1989). Randomised trial in advanced ovarian cancer comparing cisplatin and carboplatin. J. Natl Cancer Inst., 81, 1464-1471.
17. NICOLETTI I, MIGLIORATI G, PAGLIACCI MC, GRIGNANI F AND RICCARDI C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Meth., 139, 271-279.
18. NICHOLSON MC, ORR RM, O'NEILL CF AND MARRAP KR. (1992). The role of platinum uptake, glutathione levels in L1210 cells sensitive, resistant to cisplatin, tetraplatin or carboplatin. Neoplasma, 39, 189-195.
19. ORMEROD MG. (1994). Analysis of DNA. General methods. In Flow Cytometry. A Practical Approach, 2nd edn. Ormerod MG. (ed.) pp. 119-135. IRL Press at Oxford University Press: Oxford.
20. ORMEROD MG AND KUBBIES M. (1992). Cell cycle analysis of asynchronous cell populations by How cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry, 13, 678-685.
21. ORMEROD MG, PAYNE AWR AND WATSON JV. (1987). Improved program for the analysis of DNA histograms. Cytometry, 8, 637-641.
22. ORMEROD MG, COLLINS MKL, RODRIGUEZ-TARDUCHY G AND ROBERTSON D. (1992). Apoptosis in interleukin-3-dependent haemopoetic cells. Quantification by two flow cytometric methods. J. Immunol. Methods, 153, 57-65.
23. ORMEROD MG, ORR RM AND PEACOCK JH. (1994a). The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br. J. Cancer, 69, 93-100.
24. ORMEROD MG, O'NEILL CF, ROBERTSON D AND HARRAP KR. (1994b). Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res., 206, 231-237.
25. ORMEROD MG, O'NEILL CG, ROBERTSON D, KELLAND LR AND HARRAP KR. (1996). Cis-diamminedichloroplatinum(II) induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol. 37, 463-471.
26. ORR RM, O'NEILL CH, NICOLSON MC, BARNARD CJF, MURRER BA, GIANDOMENICO CM, VOLLANO JF AND HARRAP KR. (1994). Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Br. J. Cancer. 70, 415-420.
27. PENDYALA L, ARAKALI AV, SANSONE P, COWENS JW AND CREAVEN PJM. (1990). DNA binding of iproplatin and its divalent metabolite, cis-dichloro-bis-isopropylamine platinum(II). Cancer Chemother. Pharmacol., 27, 248-250.
28. POOT M AND ORMEROD MG. (1994). Analysis of cell proliferation by the bromodeoxyuridine-Hoechst/ethidium bromide method. In Flow Cytometry. A Practical Approach, 2nd edn. Ormerod MG (ed.) pp. 157-167. IRL Press at Oxford University Press: Oxford.
29. RABINOVITCH PS, KUBBIES M, CHEN YC, SCHINDLER D AND HOEHN H. (1988). BrdU-Hoechst flow cytometry. A unique tool for quantitative cell cycle analysis. Exp. Cell Res., 174, 309-318.
30. RAYNAUD FJ, ODELL DE AND KELLAND LR. (1996). Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels. Br. J. Cancer, 74, 380-386.
31. ROBERTS JJ AND FRIEDLOS F. (1987). Quantitative estimation of cisplatin-induced DNA interstrand crosslinks and their repair in mammalian cells. Pharinacol. Ther., 34, 215-246.
32. 2 arrest and DNA double strand breaks. Cancer Res., 48, 6703-6707.
33. SORENSON CM AND EASTMAN A. (1988b). Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells. Cancer Res., 48, 6703-6707.
34. 2 phase and cell death induced by cisplatin. J. Natl Cancer Inst., 82, 749-755.
35. WILTSHAW E AND CARR B. (1984). Cis-platinumdiamminedichloride. In Platinum Coordination Complexes in Cancer Chemotherapy. Connors TA and Roberts JJ (eds.) pp. 178-182. Springer-Verlag: Heidelberg.